FMU-200

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameFMU-200
Drug Alias NameFMU-200
ClassificationOther
Mechanisms of Actionc-Jun N-terminal kinase 3 inhibitors
Targetsc-Jun N-terminal kinase 3
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Vale do Taquari
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Vale do Taquari
Inactive CompaniesN/A
Active IndicationsNerve Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A